首页> 外文期刊>International Journal of Clinical Transfusion Medicine >Improving patient safety in transfusion medicine: contemporary challenges and the roles for bedside and laboratory biovigilance in addressing them
【24h】

Improving patient safety in transfusion medicine: contemporary challenges and the roles for bedside and laboratory biovigilance in addressing them

机译:改善输血医学中的患者安全性:当代挑战以及床旁和实验室生物警惕在应对这些挑战中的作用

获取原文
       

摘要

Throughout the history of hemotherapy (HT), various challenges and concerns have been encountered in its practical application. When viewed using a prismatic lens of history, recurrent themes regarding adverse HT sequelae separate and become apparent. These can be broadly classified into three categories: infectious, noninfectious, and administrative/logistical. Using the HT care map as a frame of reference along with its associated rites, we examine the contemporary spectrum of HT adverse events and concerns, and some approaches as to how these may be addressed from bedside and laboratory medicine biovigilance perspectives enhancing patient care and blood transfusion safety. Although our vantage point is from an academic community hospital venue, the issues and concerns identified are germane to many if not all transfusion-medicine practice environments. Included among the subjects we explore are patient/specimen identification issues, blood-management initiatives, unrecognized and/or unreported suspected transfusion reactions, transfusion-associated adverse pulmonary sequelae (including transfusion-related acute lung injury and transfusion-associated circulatory overload), expanded applications of electronic health records and issues regarding their “meaningful use” and interinstitutional “digital compatibilities”, biovigilance integration of electronic data networks within and between health care entities, and anticipated workforce contractions secondary to projected declines in the availability of qualified laboratory professionals. Cooperative initiatives between accreditation and regulatory entities, blood collectors and suppliers, hospital laboratory transfusion services and health care providers involved in the bedside care of the patient offer the best means in further mitigating adverse HT sequelae and potential nonconformities that may arise in the daily operations of contemporary hospital blood banks and transfusion-medicine services.
机译:在血液疗法(HT)的整个历史中,在其实际应用中遇到了各种挑战和关注。使用历史的棱柱形镜头观看时,关于不良HT后遗症的反复发作主题变得明显。这些可以大致分为三类:传染性,非传染性和行政/后勤。使用HT护理图及其相关仪式作为参考框架,我们研究了HT不良事件和忧虑的当代范围,以及如何从床边和实验室医学生物警戒的角度解决这些问题的一些方法,以增强患者护理和血液输血安全。尽管我们的观点是来自学术社区医院,但所确定的问题和担忧与许多(即使不是全部)输血医学实践环境密切相关。我们探讨的主题包括患者/样本识别问题,血液管理措施,未识别和/或未报告的疑似输血反应,与输血相关的不良肺后遗症(包括与输血相关的急性肺损伤和与输血相关的循环超负荷)电子健康记录的应用以及与它们的“有意义的使用”和机构间的“数字兼容性”有关的问题,医疗实体内部和之间的电子数据网络的生物警戒集成以及由于合格实验室专业人员的可用性下降而导致的预期劳动力收缩。认证机构和监管机构,采血者和供应商,医院实验室输血服务部门以及参与患者床边护理的医疗保健提供者之间的合作举措,是进一步减轻不良HT后遗症和日常操作中可能出现的不合格现象的最佳手段。当代医院的血库和输血医疗服务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号